Investigation on cerebrospinal fluid opioids and neurotransmitters related to spinal cord stimulation.
The purpose of this study was to assess the biochemical mechanisms underlying spinal cord stimulation (SCS). Seventeen patients with chronic pain were investigated by measuring cerebrospinal fluid concentrations of endogenous opioids and biogenic amines before and during dorsal column stimulation. Basal cerebrospinal fluid beta-endorphin levels were below the normal range. No significant change of norepinephrine, epinephrine, dopamine, beta-endorphin, beta-lipotropin, or adrenocorticotropic hormone levels were found after SCS. A 50% increase of cerebrospinal beta-endorphin and beta-lipotropin levels occurred in 6 out of 16 patients, namely those where SCS gave the major pain relief. These data confirm the derangement of the endogenous opioid system in chronic pain conditions and suggest that the beta-endorphin response to SCS could have clinical value in predicting the success of treatment.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002908:Chronic Disease; D004599:Electric Stimulation Therapy; D004723:Endorphins / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid*; D010146:Pain / Q000503:physiopathology; D059408:Pain Management; D013116:Spinal Cord / Q000503:physiopathology*; D013223:Statistics as Topic; D001615:beta-Endorphin / Q000134:cerebrospinal fluid; D008083:beta-Lipotropin / Q000134:cerebrospinal fluid
D004723:Endorphins; D018377:Neurotransmitter Agents; D001615:beta-Endorphin; D008083:beta-Lipotropin